RGX-202 is a SLC6A8 transporter inhibitor that inhibits colon cancer tumors. In addition to significantly reducing intracellular creatine phosphate and ATP levels and inducing tumor cell apoptosis, RGX-202 also inhibits creatine input in vitro and in vivo.

 

Brand: BCM

 

Target: AMPK; PPAR

 

Signaling Pathways: Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; PI3K/Akt/mTOR signaling

 

Melting Point: 222 °C (dec.)(lit.)

 

Boiling Point: 299.1±42.0 °C(Predicted)

 

pKa: 4.22±0.10(Predicted)

 

Solubility: Soluble in DMSO. Insoluble in Water; insoluble in Ethanol.

 

GHS: GHS07

 

Isomeric SMILES: C(CN=C(N)N)C(=O)O  

 

InChIKey: KMXXSJLYVJEBHI-UHFFFAOYSA-N  

 

InChI: InChI=1S/C4H9N3O2/c5-4(6)7-2-1-3(8)9/h1-2H2,(H,8,9)(H4,5,6,7)

 

Attribute
[Chem Name]	3-(diaminomethylideneamino)propanoic acid
[Synonym]	RGX-202; Ompenaclid
[CAS No.]	353-09-3
[EINECS]	206-530-0
[MDL No.]	MFCD00045939
[Formula]	C4H9N3O2
[Molecular]	131.13
[Form]	White to Off-White Solid
[Storage]	Keep in dark place. Inert atmosphere. Room temperature

Goods Tag